ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Hyperoside ameliorates cisplatin-induced acute kidney injury by regulating the expression and function of Oat1

Yuan, Wenjing; Kou, Shanshan; Ma, Ying; Qian, Yusi; Li, Xinyu; Chai, Yuanyuan; Jiang, Zhenzhou; Zhang, Luyong; Sun, Lixin; Huang, Xin*广东药学院
Xenobiotica; the fate of foreign compounds in biological systems2023-9-2DOI: 10.1080/00498254.2023.2270046
5阅读
引用收藏
分享

摘要

Cisplatin is a widely used chemotherapeutic agent to treat solid tumours in clinics. However, cisplatin-induced acute kidney injury (AKI) limits its clinical application. This study investigated the effect of hyperoside (a flavonol glycoside compound) on regulating AKI.The model of cisplatin-induced AKI was established, and hyperoside was preadministered to investigate its effect on improving kidney injury.Hyperoside ameliorated renal pathological damage, reduced the accumulation of SCr, BUN, Kim-1 and indoxyl sulphate in vivo, increased the excretion of indoxyl sulphate into the urine, and upregulated the expression of renal organic anion transporter 1 (Oat1). Moreover, evaluation of rat kidney slices demonstrated that hyperoside promoted the uptake of PAH (p-aminohippurate, the Oat1 substrate), which was confirmed by transient over-expression of OAT1 in HEK-293T cells. Additionally, hyperoside upregulated the mRNA expression of Oat1 upstream regulators hepatocyte nuclear factor-1 alpha (HNF-1 alpha) and pregnane X receptor (PXR).These findings indicated hyperoside could protect against cisplatin-induced AKI by promoting indoxyl sulphate excretion through regulating the expression and function of Oat1, suggesting hyperoside may offer a potential tactic for cisplatin-induced AKI treatment.

学科与关键词

关键词
Hyperosidecisplatinacute kidney injuryOat1indoxyl sulphate
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Xenobiotica; the fate of foreign compounds in biological systems
发表日期
2023-09-02
卷期
第 53 卷, 第 8-9 期
页码
559-571
DOI
10.1080/00498254.2023.2270046
语言
ENGLISH
成果收录
SCIE
资助标注
We thank Dr. Yi Zheng from Shandong University for providing plasmids.

作者

  • Y

    Yuan, Wenjing (第一作者)

    china pharmaceut univ

  • K

    Kou, Shanshan

    china pharmaceut univ

查看全部 10 位作者收起作者
  • M

    Ma, Ying

    nanjing univ chinese med

  • Q

    Qian, Yusi

    china pharmaceut univ

  • L

    Li, Xinyu

    china pharmaceut univ

  • C

    Chai, Yuanyuan

    china pharmaceut univ

  • J

    Jiang, Zhenzhou

    china pharmaceut univ

  • Z

    Zhang, Luyong

    guangdong pharmaceut univ

  • S

    Sun, Lixin

    china pharmaceut univ

  • H

    Huang, Xin (通讯)

    china pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417